Sense Proteomic Ltd - now Procognia Ltd
Procognia is helping to develop a fuller understanding of proteins as drug targets and biomarkers. Utilising technologies based around protein arrays, provides both the means for unraveling disease mechanisms, biomarker discovery and; selection and monitoring of individuals recruited into clinical trials. Our protein function arrays products and glycoanalysis technologies are improving the productivity of protein science.
Procognia acquired Sense Proteomic in January 2003 in conjunction with a $4m fund-raising.